SecBot SecBot
SECBOTREPLAY Home › Report › PYXS

PYXS · Director Jakob Dupont filed a Form 144 on June 30, 2026, indicating…

Pyxis Oncology, Inc. · 144 filed Jun 30, 2026 at 16:13 ET

At the news

NEUTRALIMPACT 2/10

144 filed Jun 30, 2026 at 16:13 ET

Director Jakob Dupont filed a Form 144 on June 30, 2026, indicating intent to sell 35,000 shares of Pyxis Oncology common stock, valued at approximately $107,034. The shares were acquired via a stock option exercise on the same day. This is a routine director sale following an option exercise and does not signal a change in company fundamentals.

  • Director Jakob Dupont filed Form 144 to sell 35,000 shares of Pyxis Oncology common stock.
  • Estimated sale value is approximately $107,034 based on the filing date.
  • Shares were acquired via stock option exercise on June 30, 2026.
  • The sale is to be executed through Fidelity Brokerage Services LLC.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access